Palaniyandi Kannan (Kannan Palaniyandi)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Venues

PloS one

Transboundary and emerging diseases

Current microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Rajesh Mondal, Azger Dusthackeer, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PloS one 18 (3) (2023)
Rajesh Mondal, Azger Dusthackeer, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PloS one 18 (3) (2023)
Rajesh Mondal, Azger Dusthackeer, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PloS one 18 (3) (2023)
Rajesh Mondal, Azger Dusthackeer, Palaniyandi Kannan, Amit Kumar Singh, Kannan Thiruvengadam, Radhakrishnan Manikkam, Shainaba A S, Mahizhaveni Balasubramanian, Padmasini Elango, Sam Ebenezer Rajadas, Dinesh Bharadwaj, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Hemanth Kumar A K, Manjula Singh, Shripad Patil, Jaleel U C A, Mukesh Doble, Balagurunathan R, Srikanth Prasad Tripathy, Vanaja Kumar
In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor. PloS one 18 (3) (2023)
Ananthi Rajendran, Palaniyandi Kannan
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update. Current microbiology 79 (11) (2022)
Ahmed Kabir Refaya, Harini Ramanujam, Mahaprabhu Ramalingam, Ganne Venkata Sudhakar Rao, Dhandapani Ravikumar, Devi Sangamithrai, Sivakumar Shanmugam, Palaniyandi Kannan
Tuberculosis caused by Mycobacterium orygis in wild ungulates in Chennai, South India. Transboundary and emerging diseases 69 (5) (2022)
Harini Ramanujam, Kannan Thiruvengadam, Ranjani Singaraj, Palaniyandi Kannan
Role of abattoir monitoring in determining the prevalence of bovine tuberculosis: A systematic review and meta-analysis. Transboundary and emerging diseases (2021)

Palaniyandi Kannan.css-eqlu8i{font-size:small;padding-left:4px;} (Kannan Palaniyandi)

Publication Activity (10 Years)

Top Topics

Top Venues

Palaniyandi Kannan (Kannan Palaniyandi)